Max Signaevsky
NeuroSilica, Inc.
Technologies
Materials
Indication
Brain-Computer Interface
Central Nervous System Disorders
Deep Brain Stimulation
Developmental Disorders
Functional Prosthetics
Neurodegenerative Disease
Neuromodulation
Website
neurosilica.comNeuroSilica’s objective is to develop and commercialize a novel nanotechnology–based biocompatible implantable materials for biomedical applications such as Deep Brain Stimulation and Brain-Computer Interface.
